TSHA
Taysha Gene TherapiesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-11
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
TSHA vs peer average
34/100
TSHA vs. peer average (D vs. C)
Grade spread
B 4 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
RGNX is the first available peer comparator.
REGENXBio — AAV platform with CNS/systemic programs; comparable vector and translation risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TSHA
Taysha Gene Therapies
RGNX
REGENXBIO
Grade
D
F
Momentum
50
3
Value
41
41
Sentiment
43
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs RGNX
TSHA / RGNX
Grade Position
Below peers
TSHA vs. peer average (D vs. C)
34/100
Momentum
50
TSHAValue
41
TSHASentiment
43
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TSHA
RGNX is the first peer returned for this comparison set.